Home524372 • BOM
add
Orchid Pharma Ltd
Nakaraang pagsara
₹552.85
Sakop ng araw
₹548.60 - ₹585.00
Sakop ng taon
₹471.30 - ₹898.45
Market cap
29.14B INR
Average na Volume
6.24K
P/E ratio
-
Dividend yield
-
Primary exchange
NSE
Mga balita tungkol sa merkado
.INX
1.05%
0.28%
1.40%
0.69%
Mga Financial
Income Statement
Kita
Net na kita
| (INR) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 2.07B | -4.64% |
Gastos sa pagpapatakbo | 715.86M | -4.29% |
Net na kita | -126.14M | -160.71% |
Net profit margin | -6.09 | -163.70% |
Kita sa bawat share | -1.08 | — |
EBITDA | 10.45M | -95.93% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (INR) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 1.49B | -39.11% |
Kabuuang asset | — | — |
Kabuuang sagutin | — | — |
Kabuuang equity | 12.74B | — |
Natitirang share | 50.66M | — |
Presyo para makapag-book | 2.20 | — |
Return on assets | — | — |
Return on capital | -1.20% | — |
Cash Flow
Net change in cash
| (INR) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -126.14M | -160.71% |
Cash mula sa mga operasyon | — | — |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | — | — |
Net change in cash | — | — |
Malayang cash flow | — | — |
Tungkol
Orchid Pharma Limited is an Indian pharmaceutical company based in Chennai. It was founded by Kailasam Raghavendra Rao on 1 July 1992. Orchid Pharma is the only pharma company in India to have discovered a New Drug Enmetazobactam which is now approved in United States, Europe and India. Wikipedia
Itinatag
1992
Website
Mga Empleyado
736